If you or a loved one suffered vision loss after taking Wegovy, please contact our team to discuss possible compensation from a Wegovy vision-loss lawsuit
GLP-1 receptor agonists, such as semaglutide (sold under the brand names Ozempic and Wegovy), are rapidly becoming one of the most prescribed treatments for type 2 diabetes and weight loss
November 1, 2024: FDA Issues Warning To Patients Taking Compounded Semaglutide Drugs In October, the FDA issued a letter titled, FDAs Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. In the letter, the FDA warned people taking compounded versions of GLP-1 drugs for weight loss
The possibility of offering new hope to individuals struggling with addiction is what makes this work so meaningful. Original study: DOI 10.1038/s41598-025-17927-w Authors: Fatima Quddos, graduate, Virginia Tech Translational Biology, Medicine, and Health Graduate Program Mary Fowler, research assistant and programs coordinator, Fralin Biomedical Research Institute at VTC Ana Carolina de Lima Bovo, Ph.D., postdoctoral associate, Fralin Biomedical Research Institute at VTC Zacarya Elbash, research assistant, Fralin Biomedical Research Institute at VTC Allison N